Key Research Focus Intezyne Technologies specializes in developing novel anti-cancer therapies, positioning them as a key player in the biotechnology research industry. Their focus on increasing the effectiveness of cancer treatments presents a significant sales opportunity for partnerships with healthcare providers and institutions seeking cutting-edge solutions.
Strategic Partnerships Recent partnerships with companies like Exosome Diagnostics showcase Intezyne's commitment to collaboration and innovation. Leveraging these partnerships, sales development representatives can explore opportunities to introduce Intezyne's proprietary assets to a broader market, potentially leading to new business relationships and revenue streams.
Financial Investment Securing $10 million in Series A funding indicates investor confidence in Intezyne's capabilities and potential growth. This financial backing not only strengthens the company's position but also signals to potential clients and partners the stability and viability of engaging with Intezyne for long-term collaborations and investments.
Expansion in Leadership The addition of key personnel like Glenn Walthall and David K. Robb to Intezyne's board of directors signifies a strategic move towards enhancing corporate governance and expertise. Sales development representatives can leverage these experienced individuals to establish credibility and explore sales opportunities with stakeholders who value strong leadership and industry insights.
Market Differentiation With a focus on Cancer Resistance Pathway (CRP) inhibitors, Intezyne sets itself apart by offering a unique approach to cancer treatment. Sales development professionals can position Intezyne as a pioneer in this specialized niche, appealing to healthcare providers and research institutions looking for innovative therapies that address critical unmet needs in oncology.
Intezyne Technologies uses 8 technology products and services including Amazon CloudFront, Font Awesome, jQuery, and more. Explore Intezyne Technologies's tech stack below.
| Intezyne Technologies Email Formats | Percentage |
| First.Last@intezyne.com | 41% |
| Last.First@intezyne.com | 9% |
| First.Last@intezyne.com | 41% |
| Last.First@intezyne.com | 9% |
Biotechnology ResearchFlorida, United States2-10 Employees
Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets. The Company is currently advancing these assets through various stages of the clinical approval process.
Company Overview
Media & News
Funding & FinancialsIntezyne Technologies has raised a total of $10M of funding over 2 rounds. Their latest funding round was raised on Oct 06, 2017 in the amount of $10M.
Intezyne Technologies's revenue is in the range of $10M
Funding & FinancialsIntezyne Technologies has raised a total of $10M of funding over 2 rounds. Their latest funding round was raised on Oct 06, 2017 in the amount of $10M.
Intezyne Technologies's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com